 Telegraph.co.uk |
Glaxo's Experimental Drug Halves Asthma Attacks in Study
Businessweek Among 621 participants with severe asthma, after a year of treatment, the rate of attacks requiring oral corticosteroids, emergency room visits or hospitalizations was about half for those taking one of three monthly doses of the drug, called … Experimental Drug May Cut Severe Asthma Attacks: Study GSK drug halves attacks in hard-to-treat asthma Experimental drug halves attacks in hard-to-treat asthma |
View full post on asthma – Google News